Physician profile
Van A Johnson
NPI 1356545040
$4,120.68
in general payments reported to CMS, 2019-2025
9 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.96 · 2022: $28.76 · 2023: $3,697 · 2024: $176 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,070 · Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,069.70 |
| Food and Beverage | $463.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,773.46 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $107.08 | 2025 | Arista |
| Kls-Martin L.P. | $52.60 | 2025 | |
| Integra Lifesciences Corporation | $44.53 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Janssen Pharmaceuticals, INC | $44.02 | 2019 | |
| Polynovo North America LLC | $41.19 | 2023-2024 | Novosorb Btm |
| Tela Bio, INC. | $28.76 | 2022 | |
| Kci USA, INC. | $14.94 | 2019 | |
| Medtronic, INC. | $14.10 | 2023 | Aquamantys(Tm) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Van Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.